SCHEMBL6431460

SCHEMBL6431460

N[C@@H]1CCCC[C@H]1N(Cc1ccc(Br)cc1)Cc1ccc(Br)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.37
CYP2D6 P10635 2/20 0.37
CYP2C9 P11712 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM1A O60341 5/20 0.35
KCNH2 Q12809 3/20 0.35
MAOB P27338 3/20 0.35
RCOR1 Q9UKL0 2/20 0.35
KDM1B Q8NB78 1/20 0.35
PYCR1 P32322 3/20 0.35
HRH4 Q9H3N8 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
ABCB11 O95342 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
AR P10275 1/20 0.33
SLC6A2 P23975 1/20 0.33
PDE4A P27815 1/20 0.33
SLC6A4 P31645 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3899507 1.00 SIGMAR1 (0.37) SIGMAR1CYP2D6CYP2C9HSD17B10MEN1
SCHEMBL2197649 0.83 SLC18A3 (0.49) SIGMAR1MEN1KMT2ASLC6A2SLC6A4
SCHEMBL490929 0.83 SLC18A3 (0.49) SIGMAR1MEN1KMT2ASLC6A2SLC6A4
SCHEMBL2936927 0.83 SLC18A3 (0.49) SIGMAR1MEN1KMT2ASLC6A2SLC6A4
SCHEMBL29615873 0.83 SLC18A3 (0.49) SIGMAR1MEN1KMT2ASLC6A2SLC6A4
Bromide SCHEMBL19897327 0.81 SLC18A3 (0.47) SIGMAR1MEN1KMT2ASLC6A2SLC6A4
Bromide SCHEMBL19897108 0.81 SLC18A3 (0.47) SIGMAR1MEN1KMT2ASLC6A2SLC6A4
Bromide SCHEMBL16799712 0.81 SLC18A3 (0.47) SIGMAR1MEN1KMT2ASLC6A2SLC6A4
Bromide SCHEMBL20398790 0.80 SLC18A3 (0.46) SIGMAR1MEN1KMT2ASLC6A2SLC6A4
SCHEMBL6407300 0.80 KCNA5 (0.43) SIGMAR1CYP2D6KDM1AMAOBPYCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288525-A1 Reagents for asymmetric allylation, aldol, and tandem aldol and allylation reactions NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-12-29 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288525-A1 Reagents for asymmetric allylation, aldol, and tandem aldol and allylation reactions AKR1C3, AKR1B10, CBR3 SIGMAR1 451/4885CYP2D6 268/4885CYP2C9 226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.